OAJ
EVOK

Ogorek Anthony Joseph’s Evoke Pharma EVOK Stock Holding History

Ogorek Anthony Joseph’s Portfolio EVOK Stock Details EVOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-25
Closed -$6K – 203
2021
Q1 		$6K Hold
25
– – ﹤0.01% 167
2020
Q4 		$9K Buy
+25
New +$12.9K ﹤0.01% 144

Other funds holding EVOK

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Ogorek Anthony Joseph's EVOK Position: Q2 2021 in Review

Ogorek Anthony Joseph sold out of Evoke Pharma (EVOK) in Q2 2021, closing a stake of 25 shares — an estimated $6K sold.

Ogorek Anthony Joseph first reported a position in EVOK in Q4 2020 and held it in 2 quarters. The position peaked at $9K in Q4 2020. 19 funds tracked by Wall St. Rank hold EVOK as of Q2 2021.

  • Ogorek Anthony Joseph reported no remaining Evoke Pharma position as of Q2 2021 after selling out during the quarter.
  • Ogorek Anthony Joseph sold 25 Evoke Pharma shares in Q2 2021, an estimated $6K.
  • Ogorek Anthony Joseph first reported a position in Evoke Pharma in Q4 2020 and held it in 2 quarters.
  • Ogorek Anthony Joseph's Evoke Pharma position peaked at $9K in Q4 2020.
  • 19 funds tracked by Wall St. Rank held Evoke Pharma as of Q2 2021.

Based on Ogorek Anthony Joseph's 13F filing for Q2 2021, filed 14 Jul 2021.